RCS - Pareto Securities AS - Sale to IVC Evidensia Group
02/08/2022 11:30
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220802:nRSB6141Ua&default-theme=true
RNS Number : 6141U Pareto Securities AS 02 August 2022
Pareto Securities advises the shareholders of Tierklinik Hofheim on the sale
to IVC Evidensia Group
· Pareto lays foundation for successful closing with customized
transaction structure and access to relevant financial and strategic investors
in the animal health sector
· Divestment of the largest animal hospital in Germany is
considered a lighthouse
transaction in the international animal health market
· Pareto with special expertise in advising and implementing
projects in the areas of M&A and business succession
Frankfurt, August 2, 2022 - The German branch of Pareto Securities AS, an
international investment bank headquartered in Oslo and a long-standing
partner of SMEs in Germany, announces that, following the approval of the
German Federal Cartel Office and the execution of the closing conditions, the
sale of the veterinary hospital Hofheim near Frankfurt has been successfully
completed. Pareto has thus achieved an important milestone in the German
animal health market. The buyer is the internationally operating IVC Evidensia
Group, which has already acquired numerous veterinary clinics and practices in
Europe and Canada. The sale of the Hofheim veterinary clinic represents a
lighthouse transaction, in terms of the size of the transaction and reputation
of the animal clinic in the industry. With the acquisition, IVC Evidensia
intends to sustainably develop the leading market position of the Hofheim
veterinary clinic and achieve synergies in the medical sector.
Lutz Weiler, CEO Pareto Securities Germany, explains: "With the tailor-made
transaction structure, we as Pareto contributed to the successful completion
of the transaction of Tierklinik Hofheim, which was thereby implemented highly
efficiently within only five months. This ensured an appropriate continuation
of the entrepreneurial activities of the veterinary clinic and created maximum
flexibility in the context of the company succession. Also important for the
success of the transaction was the involvement of the long-term (or current)
top performers, for whom attractive prospects could be agreed. As Pareto, we
have established access to the relevant international investors in the animal
health sector. Thus, the relevant facilities or the veterinarians involved
benefit from our many years of experience and numerous transactions in the
field of healthcare services".
Christoph Vigelius, Partner Investment Banking at Pareto Securities Germany,
continues: "The market for animal health is not only a growing market, but it
also faces significant structural challenges, which offer opportunities for
veterinarians and investors alike. Germany and also other European regions are
currently moving more and more into the focus of investors and are thus
following the development that can already be traced internationally. In our
discussions with the veterinary clinics and veterinarians, we see a growing
interest in going new ways, also in terms of a change in ownership, in order
to strive for a good succession plan".
As the market leader in Germany, Tierklinik Hofheim is also one of the largest
veterinary clinics in Europe. Since its founding in 1997, the animal clinic
can look back on a total of 25 years of growth and today has more than 300
employees and 100 veterinarians. As a referral-only clinic, Hofheim Animal
Hospital does not compete with smaller veterinary practices. The reputation of
the Hofheim Veterinary Clinic is outstanding, as about 25% of all
veterinarians in Germany have already referred patients and their owners to
the Hofheim Veterinary Clinic for treatment.
In view of the continuing growth of the global market for pet supplies, the
transaction is under positive omens. Pet owners are becoming increasingly
health-oriented, and with this comes a growing demand for high-quality
services and products. The market is also benefiting from medical advances and
the increasing willingness of pet owners to invest significantly in extending
the life of their pets.
Pareto Securities has become an ideal partner in the healthcare sector with
more than 40 transactions in the last three years. This includes another
transaction in the animal health market this year with a capital increase of
approximately EUR 340 million for the company Swedencare AB. In the healthcare
market, Pareto Securities, with its services in the areas of "Equity Capital
Markets", "Debt Capital Markets" and "Mergers and Acquisitions", has extensive
experience and a comprehensive network covering the areas of veterinary
services as well as, in the area of human medicine, clinics, outpatient and
inpatient care, diagnostics and laboratories, medical technology and private
equity.
About Pareto Securities
Founded in 1986, Pareto Securities is headquartered in Norway and has offices
in Denmark, Finland, Sweden, France, Germany, the UK, Switzerland, the US,
Singapore and Australia. Pareto Securities has a leading position in the
Nordic financial markets and a strong international presence. Pareto
Securities offers a wide range of financial services, including equity and
fixed income brokerage, equity, debt and project finance, and advisory
services related to mergers and acquisitions and restructuring.
Contact: Press contact:
Pareto Securities AS cometis AG
Frankfurt Branch Claudio Sabatelli
Count Str. 97 Tel.: +49 (611) 20 58 55-24
60487 Frankfurt Fax: +49 (611) 20 58 55-66
Tel.: +49 (69) 58997-0 E-mail: sabatelli@cometis.de (mailto:sabatelli@cometis.de)
E-mail: info@paretosec.com http://www.cometis.de
(https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=a78baf68b4789aa7eb92b859a6e6bd9a&application_id=1379341&site_id=news_data&application_name=news)
http://www.paretosec.com
(https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=bebdbc2bc2c4137ffe8dcdc7aae4187d&application_id=1379341&site_id=news_data&application_name=news)
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NRAZZGGRLZKGZZG